European Expert Consortium to Develop a Novel Pandemic Flu Vaccine - - BioPharm International

ADVERTISEMENT

European Expert Consortium to Develop a Novel Pandemic Flu Vaccine

BioPharm Bulletin

Five European organizations, including three companies and two hospitals, have joined forces to develop a novel pandemic influenza vaccine as a potential emergency vaccination.

The four-year FluVac project, as it will be called, has been awarded a grant of €3.5 million from the European Union to help fund the research and the development of a new vaccine. Nobilon International BV will coordinate the project. The FluVac project consortium consists of Nobilon International BV (Boxmeer, the Netherlands), Protherics PLC (Cheshire, UK), Retroscreen Virology Ltd (London, UK), Erasmus Medical Centre (Rotterdam, the Netherlands), and Landspitali University Hospital (Reykjavik, Iceland).

Nobilon release

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
PDA Announces Technical Report on Drug Shortages
September 9, 2014
Infinity and AbbVie Collaborate to Develop Oncology Drug
September 5, 2014
Merck KGaA Breaks Ground on Facility in China
September 5, 2014
DPT Laboratories Acquires Media Pharmaceuticals' Lakewood Facilities
September 5, 2014
Author Guidelines
Source: BioPharm Bulletin,
Click here